Huge cost of opioid epidemic
New research from Pennsylvania State University has reported that the opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XNew research from Pennsylvania State University has reported that the opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax
Scientists at the University of Massachusetts Medical School have developed a strategy for editing and repairing a particular type of genetic mutation associated with microduplications using CRISPR/Cas9 and
Defensive compounds produced by microbes are an important source of antibiotics and other medicines. However, in light of the increasing resistant microbes, researchers are taking their search for
The Epilepsy Society has recently spoken out about the 'steep rise' in UK patients experiencing difficulty in accessing seizure medication. While issues may have been affected by Brexit, the
Many older adults live in ethnically diverse rural settings where they face a higher risk of developing Alzheimer's disease (AD) but often delayed diagnosis of the condition due
A clinical review, published at the end of last week in the BMJ, provides new interim advice for healthcare professionals interested in prescribing cannabis-based products and cannabinoids to
The autoimmune disease lupus, which can cause fatigue, a facial rash, and joint pain, occurs much more commonly in females than males, representing 85% of cases. It is
Gnosis by Lesaffre (formerly Lesaffre Human Care), business unit of Lesaffre Group dedicated to nutrition, health and personal care businesses, is raising awareness about ibSium with the launch
In the largest genetic study of osteoarthritis to date, scientists have uncovered 52 new genetic changes linked to the disease, which doubles the number of genetic regions associated
The UK pharma industry has called for a temporary medicines export ban to prevent the NHS from being hit by national drugs shortage in the event of no-deal